πŸ‡ΊπŸ‡Έ FDA
Patent

US 7008923

Glycopeptide phosphonate derivatives

expired A61KA61K38/14A61K47/06

Quick answer

US patent 7008923 (Glycopeptide phosphonate derivatives) held by Theravance, Inc. expires Mon Mar 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Mar 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/14, A61K47/06, A61K47/12, A61K47/26